Skip to main content
BASKHANBIOPharma Inc. logo

BASKHANBIOPharma Inc. — Investor Relations & Filings

Ticker · 354390 ISIN · KR7354390007 KO Manufacturing
Open in API
Filings indexed 71 across all filing types
Latest filing 2024-06-05 Report Publication Anno…
Country KR South Korea
Listing KO 354390

About BASKHANBIOPharma Inc.

http://www.baskhanbio.com/

BASKHANBIOPharma Inc. is a pharmaceutical company focused on pain management and improving patient quality of life. The company engages in the manufacture, sale, and distribution of a diverse product portfolio. Its core offerings include prescription drugs, over-the-counter (OTC) medicines, and medical devices, with a particular emphasis on products used before, during, and after surgical procedures. In addition to its primary pharmaceutical and medical device operations, the company's business areas also encompass health functional foods and cosmetics.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling of an Investor Relations (IR) meeting (기업설명회). It provides details such as the date, time, location, purpose, and target audience for the upcoming event. Since this is an announcement of an event rather than the presentation materials themselves or a full report, and it fits the regulatory requirement for disclosing corporate events to the exchange, it is classified as a Regulatory Filing (RNS).
2024-06-05 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including stock options and director changes, for (주)바스칸바이오제약. This falls under the category of Major Shareholding Notification (MRQ) as it tracks significant ownership thresholds and changes in control.
2024-03-28 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회 결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including the approval of financial statements, director appointments, and compensation limits. This matches the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it reports the official outcomes of shareholder votes at an AGM.
2024-03-26 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Supervisory Service/Korea Exchange. It details the issuance of stock options to employees, including the number of shares, exercise price, and legal basis. This type of disclosure regarding capital structure changes and employee compensation via stock options is classified as a regulatory filing under the RNS category.
2024-03-26 Korean
사업보고서 (2023.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Baskan Bio Pharm' (주식회사 바스칸바이오제약) for the fiscal year ending December 31, 2023. It includes the independent auditor's opinion, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. This is a comprehensive financial audit document, not an earnings release or a simple announcement. FY 2023
2024-03-18 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal filing titled '감사보고서 제출' (Submission of Audit Report) by Baskan Bio Pharm. It provides the audit opinion (적정/Unqualified), key financial data (assets, liabilities, revenue, profit), and the name of the auditor (Hanul Accounting Corp). While it contains financial data, it is specifically a regulatory disclosure announcing the submission of the audit report to the exchange, which fits the definition of an Audit Report/Information filing. FY 2023
2024-03-12 Korean

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.